This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated September 2026 quarter: revenue up 37 percent, profit after tax up 82 percent
BALAMINES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts less than Nifty Microcap 250 and 3.3 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the consolidated quarter ended 30 September 2026, revenue from operations rose 37.3 percent year on year to Rs 46,759.93 lakh from Rs 34,055.21 lakh, and profit after tax rose 81.9 percent to Rs 6,747.20 lakh from Rs 3,710.21 lakh. Margin before depreciation, interest and tax widened from 17.6 percent to 21.7 percent. Consolidated half-year profit after tax was Rs 14,558.87 lakh. Auditors found no issue; the board noted an SEBI warning.
Strong sales, profit and margin growth should support positive sentiment, but the SEBI warning remains a regulatory concern.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹467.6 Cr | ₹340.6 Cr | +37.3% |
| Operating profit | ₹84.92 Cr | ₹44.57 Cr | +90.5% |
| Profit after tax | ₹67.47 Cr | ₹37.10 Cr | +81.9% |
| EBITDA margin | 21.7% | 17.6% | +4.2 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.